1357945-49-3

Basic information

• Product Name: 3-c]pyridine
• Synonyms: 6-bromo-3-iodo-1H-pyrazolo[4,3-c]pyridine;6-bromo-3-iodo-2H-pyrazolo[4,3-c]pyridine
• CAS NO: 1357945-49-3
• Molecular Formula: C6H3BrIN3
• Molecular Weight: 323.91659
• Mol File: 1357945-49-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 458.7±40.0 °C(Predicted)
• Appearance: /
• Density: 2.559±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 8.47±0.40(Predicted)
• CAS DataBase Reference: 3-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-c]pyridine(1357945-49-3)
• EPA Substance Registry System: 3-c]pyridine(1357945-49-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 1357945-49-3(Hazardous Substances Data)

Upstream product

• 1256789-73-7 methyl 6-bromo-4-chloropyridine-3-carboxylate 
• 1206973-12-7 6-bromo-1H-pyrazolo[4,3-c]pyridine 
• 1364663-37-5 2-bromo-4-chloro-5-iodopyridine 
• 1300750-78-0 4-amino-2-bromo-5-iodopyridine 
• 7598-35-8 2-bromo-4-aminopyridine 

Relevant articles and documents

Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor

Inhibitors targeting the activating mutants of the epidermal growth factor receptor (EGFR) have found success in the treatment of EGFR mutant positive non-small-cell lung cancer. A secondary point mutation (T790M) in the inhibitor binding site has been li

AZAINDAZOLE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS

This invention relates to novel compounds of formula (I), which are inhibitors of T790M containing EGFR mutants, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of cancer.